NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 262 filers reported holding NEOGENOMICS INC in Q4 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 40 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 40 | -86.7% | 0.00% | -100.0% |
| Q3 2021 | $14,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $14,000 | -12.5% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $16,000 | +45.5% | 300 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $11,000 | +22.2% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $9,000 | +12.5% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $8,000 | -11.1% | 300 | 0.0% | 0.00% | -40.0% |
| Q4 2019 | $9,000 | +50.0% | 300 | 0.0% | 0.01% | +25.0% |
| Q3 2019 | $6,000 | +50.0% | 300 | +50.0% | 0.00% | +100.0% |
| Q2 2019 | $4,000 | -95.0% | 200 | -94.9% | 0.00% | -95.9% |
| Q1 2019 | $80,000 | – | 3,892 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,785,605 | $86,138,000 | 34.19% |
| PERKINS CAPITAL MANAGEMENT INC | 157,750 | $7,610,000 | 4.71% |
| Blue Water Life Science Advisors, LP | 222,222 | $10,719,000 | 3.49% |
| First Light Asset Management, LLC | 1,055,960 | $50,940,000 | 3.36% |
| Ranger Investment Management | 810,956 | $39,121,000 | 2.09% |
| Bullseye Asset Management LLC | 108,054 | $5,212,000 | 1.81% |
| Lombard Odier Asset Management (Switzerland) SA | 584,281 | $28,186,000 | 1.75% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 998,858 | $48,185,000 | 1.67% |
| EMERALD ADVISERS, LLC | 904,298 | $43,623,000 | 1.58% |
| Soleus Capital Management, L.P. | 190,556 | $9,192,000 | 1.43% |